• Stumpff and Colleagues Discover Cancer Cell Vulnerability - a Potential Target for New Cancer Treatments
    February 22, 2021
  • Doublie & Colleagues Discover Dual Function in Enzyme Critical for Cancer Growth
    February 11, 2021
    In developing therapies for hard-to-treat breast and ovarian cancers in patients with BRCA gene mutations, scientists aim to identify ways to keep cancer cells from using DNA break repair pathways. New findings from researchers including UVM Professor Sylvie Doublie demonstrate a previously-unknown capability for a key enzyme in this repair function that shows promise as a new avenue for treatment development.
  • Lester-Coll Study Finds Lower Costs, Better Outcomes in Prostate Cancer Therapy
    January 21, 2021
    An interdisciplinary team of Vermont researchers and a partner at Yale's Smilow Cancer Center, conducted an economic evaluation to establish an overall cost-effectiveness comparison of two approaches to the treatment of low-volume metastatic prostate cancer. Their findings, published in JAMA Network Open, strongly support the addition of prostate radiation therapy to standard androgen deprivation therapy.
  • Cancer Rehab Program Transforms to Meet Needs of Survivors During COVID-19
    January 7, 2021
    Despite the many challenges presented by the pandemic, the resilience of UVM Cancer Center patients and continued commitment of providers have led to a silver lining: a way to ensure patients in locations throughout Vermont and upstate New York are receiving the physical and mental health support they need right from the comfort of their own homes.
  • Villanti, Copeland Named to List of World’s Most Influential Researchers
    November 19, 2020
    UVM faculty members Andrea Villanti, Ph.D., M.P.H., associate professor of psychiatry, and William Copeland, Ph.D., professor of psychiatry, have been named to a list of the world’s most influential researchers - the Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.
  • Memorial Sloan Kettering’s Brentjens Delivers 5th Annual Stetson Lecture
    September 4, 2020
    Renier Brentjens, M.D., Ph.D., director of cellular therapeutics in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, presented the 5th Annual Stetson Lecture in Technological Advances in Medicine via Zoom on September 8. He discussed “CARs and Armored CARs: Improving CAR T Cell Therapy for Cancer.”
  • Villanti Substance Use Prevention Studies' Novel Approach Keeps Youth Engaged
    August 11, 2020
    New findings from a collaborative Vermont study published in the Journal of Medical Internet Research highlight how having a uniquely flexible survey instrument and using incentives can help capture the most relevant data and keep young Vermonters engaged.
  • Larner Grants Lead in Record-Setting Year for UVM Research Funding
    August 7, 2020
    The University of Vermont received $181.7 million in research funding during the 2020 fiscal year - the largest in UVM history by a wide margin. The Larner College of Medicine had the largest number of grants.
  • Vermont Integrative Genetics Resource Celebrates Milestones, Grant Support
    June 18, 2020
    Despite the many challenges academic institutions have faced in 2020, the Vermont Integrative Genetics Resource (VIGR) shared core facility at the University of Vermont Cancer Center and Larner College of Medicine has achieved strong funding support and achieved some significant milestones over the past six months.
  • Thomas Comments on Helping Cancer Patient Families Cope during COVID-19 in Neurology Today
    May 18, 2020
    (MAY 18, 2020) Alissa Thomas, M.D., assistant professor of neurological sciences and residency director for neurology, was featured in a Neurology Today article, titled "Neuropalliative Care During COVID-19—How Clinicians Help Patients and Families Cope with Isolation, Fear, and Life-Limiting Illness."
  • Adrianzen-Herrera Discusses Benefits of Telemedicine with Cancer Patients in ASCO Daily News
    May 13, 2020
    (MAY 13, 2020) University of Vermont Assistant Professor of Medicine Diego Adrianzen-Herrera was interviewed for an ASCO Daily News special series on treating patients with cancer in the wake of COVID-19.
  • Holmes and Stein Named 2020-21 UVM University Scholars
    May 8, 2020
    Larner College of Medicine faculty members Gregory Holmes, M.D., professor and chair of neurological sciences, and Gary Stein, Ph.D., Perelman professor and chair of biochemistry, have been selected as University Scholars for the 2020-21 academic year.
  • American Academy of Arts & Sciences Elects Susan Wallace to Its Membership
    April 27, 2020
    The American Academy of Arts & Sciences has announced the election of University of Vermont Professor of Microbiology and Molecular Genetics Emerita Susan Wallace, Ph.D., to its membership, in recognition of her status as a world leader in the sciences. Wallace joins 275 new members elected on April 23, 2020.
  • Celebrating Student Research
    April 22, 2020
    Over one dozen Larner College of Medicine medical, doctoral students and Master of Public Health degree students recently presented their research alongside hundreds of peers from across UVM for the first-ever virtual Student Research Conference.
  • Cancer Center Team Presents National Model to Reduce Blood Clots in Patients
    April 21, 2020
    Often-deadly blood clots are a common complication of cancer care, yet less than five percent of patients receive education on how to prevent them. A team of clinician-researchers at the UVM Cancer Center have published an evidence-based prevention “roadmap” found to reduce blood clots by 38 percent in the highest-risk patients.
  • Bates and Vermont Team Invent Emergency Ventilator
    May 5, 2020
    Over the last three weeks, a team of scientists, engineers and doctors at the University of Vermont, including Professor of Medicine Jason Bates, have developed a new design—and built a working model—for a simple, inexpensive ventilator.
  • Sprague Study Suggests Improved Breast Cancer Screening with 3D Mammography
    March 31, 2020
    Research findings, published in JAMA Network Open and led by University of Vermont Cancer Center researcher Brian Sprague, Ph.D., show that breast cancer screening with digital breast tomosynthesis (also known as 3D mammography) improves breast cancer screening performance among most radiologists.
  • Goldman Named Inaugural Follansbee Professor
    February 4, 2020
    Glenn Goldman, M.D., professor of medicine and chief of dermatology, was invested as the inaugural Rogers and Nancy Follansbee Professor of Dermatology during a formal ceremony held February 3, 2020 at the Larner College of Medicine at the University of Vermont.
  • Gramling Study Finds Machine Learning Illuminates End-of-Life Conversations
    December 9, 2019
    Researchers at the University of Vermont’s Vermont Conversation Lab, including Miller Chair of Palliative Medicine Robert Gramling, M.D., D.Sc., have used machine learning and natural language processing to better understand what conversations surrounding life-threatening and serious illnesses look like, in order to help healthcare providers improve their end-of-life communication. Their work was published December 9 in the journal Patient Education and Counselling.
  • Cushman and Copeland Named to List of World’s Most Influential Researchers
    November 20, 2019
    Two University of Vermont Larner College of Medicine faculty have been named to a list of the world’s most influential researchers, based on the number of times their published studies have been cited by other researchers over the past decade. Researchers on the list are in the top 1 percent of all scholars whose work has been cited. The prestigious Highly Cited Researchers list is compiled and published annually by Clarivate Analytics.